BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 27903962)

  • 1. Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.
    Sequeiros T; Rigau M; Chiva C; Montes M; Garcia-Grau I; Garcia M; Diaz S; Celma A; Bijnsdorp I; Campos A; Di Mauro P; Borrós S; Reventós J; Doll A; Paciucci R; Pegtel M; de Torres I; Sabidó E; Morote J; Olivan M
    Oncotarget; 2017 Jan; 8(3):4960-4976. PubMed ID: 27903962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.
    Fujita K; Kume H; Matsuzaki K; Kawashima A; Ujike T; Nagahara A; Uemura M; Miyagawa Y; Tomonaga T; Nonomura N
    Sci Rep; 2017 Feb; 7():42961. PubMed ID: 28211531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.
    Xu Y; Qin S; An T; Tang Y; Huang Y; Zheng L
    Prostate; 2017 Jul; 77(10):1167-1175. PubMed ID: 28617988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of urinary extracellular vesicles in prostate cancer is associated with altered urinary N-glycosylation profile.
    Vermassen T; D'Herde K; Jacobus D; Van Praet C; Poelaert F; Lumen N; Callewaert N; Decaestecker K; Villeirs G; Hoebeke P; Van Belle S; Rottey S; Delanghe J
    J Clin Pathol; 2017 Oct; 70(10):838-846. PubMed ID: 28360190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of two gene panels for prostate cancer diagnosis and patient risk stratification.
    Xiao K; Guo J; Zhang X; Feng X; Zhang H; Cheng Z; Johnson H; Persson JL; Chen L
    Tumour Biol; 2016 Aug; 37(8):10115-22. PubMed ID: 26820133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer.
    Royo F; Zuñiga-Garcia P; Torrano V; Loizaga A; Sanchez-Mosquera P; Ugalde-Olano A; González E; Cortazar AR; Palomo L; Fernández-Ruiz S; Lacasa-Viscasillas I; Berdasco M; Sutherland JD; Barrio R; Zabala-Letona A; Martín-Martín N; Arruabarrena-Aristorena A; Valcarcel-Jimenez L; Caro-Maldonado A; Gonzalez-Tampan J; Cachi-Fuentes G; Esteller M; Aransay AM; Unda M; Falcón-Pérez JM; Carracedo A
    Oncotarget; 2016 Feb; 7(6):6835-46. PubMed ID: 26771841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity Captured Urinary Extracellular Vesicles Provide mRNA and miRNA Biomarkers for Improved Accuracy of Prostate Cancer Detection: A Pilot Study.
    Davey M; Benzina S; Savoie M; Breault G; Ghosh A; Ouellette RJ
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Vesicle Proteome in Prostate Cancer: A Comparative Analysis of Mass Spectrometry Studies.
    Bernardino RMM; Leão R; Henrique R; Pinheiro LC; Kumar P; Suravajhala P; Beck HC; Carvalho AS; Matthiesen R
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential tissue expression of extracellular vesicle-derived proteins in prostate cancer.
    Duijvesz D; Rodriguez-Blanco G; Hoogland AM; Verhoef EI; Dekker LJ; Roobol MJ; van Leenders GJLH; Luider TM; Jenster G
    Prostate; 2019 Jun; 79(9):1032-1042. PubMed ID: 31018022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation.
    Ciardiello C; Leone A; Lanuti P; Roca MS; Moccia T; Minciacchi VR; Minopoli M; Gigantino V; De Cecio R; Rippa M; Petti L; Capone F; Vitagliano C; Milone MR; Pucci B; Lombardi R; Iannelli F; Di Gennaro E; Bruzzese F; Marchisio M; Carriero MV; Di Vizio D; Budillon A
    J Exp Clin Cancer Res; 2019 Jul; 38(1):317. PubMed ID: 31319863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of urinary and tissue-exudative extracellular vesicles to discover novel bladder cancer biomarkers.
    Tomiyama E; Matsuzaki K; Fujita K; Shiromizu T; Narumi R; Jingushi K; Koh Y; Matsushita M; Nakano K; Hayashi Y; Wang C; Ishizuya Y; Kato T; Hatano K; Kawashima A; Ujike T; Uemura M; Takao T; Adachi J; Tomonaga T; Nonomura N
    Cancer Sci; 2021 May; 112(5):2033-2045. PubMed ID: 33721374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression.
    Andreu Z; Otta Oshiro R; Redruello A; López-Martín S; Gutiérrez-Vázquez C; Morato E; Marina AI; Olivier Gómez C; Yáñez-Mó M
    Eur J Pharm Sci; 2017 Feb; 98():70-79. PubMed ID: 27751843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoscale flow cytometry to distinguish subpopulations of prostate extracellular vesicles in patient plasma.
    Padda RS; Deng FK; Brett SI; Biggs CN; Durfee PN; Brinker CJ; Williams KC; Leong HS
    Prostate; 2019 May; 79(6):592-603. PubMed ID: 30680751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer.
    Signore M; Alfonsi R; Federici G; Nanni S; Addario A; Bertuccini L; Aiello A; Di Pace AL; Sperduti I; Muto G; Giacobbe A; Collura D; Brunetto L; Simone G; Costantini M; Crinò L; Rossi S; Tabolacci C; Diociaiuti M; Merlino T; Gallucci M; Sentinelli S; Papalia R; De Maria R; Bonci D
    Cell Death Dis; 2021 Jun; 12(7):636. PubMed ID: 34155195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis.
    Pang B; Zhu Y; Ni J; Thompson J; Malouf D; Bucci J; Graham P; Li Y
    Theranostics; 2020; 10(5):2309-2326. PubMed ID: 32089744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aqueous two-phase system to isolate extracellular vesicles from urine for prostate cancer diagnosis.
    Shin H; Park YH; Kim YG; Lee JY; Park J
    PLoS One; 2018; 13(3):e0194818. PubMed ID: 29584777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using gene expression from urine sediment to diagnose prostate cancer: development of a new multiplex mRNA urine test and validation of current biomarkers.
    Mengual L; Lozano JJ; Ingelmo-Torres M; Izquierdo L; Musquera M; Ribal MJ; Alcaraz A
    BMC Cancer; 2016 Feb; 16():76. PubMed ID: 26856686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate extracellular vesicles in patient plasma as a liquid biopsy platform for prostate cancer using nanoscale flow cytometry.
    Biggs CN; Siddiqui KM; Al-Zahrani AA; Pardhan S; Brett SI; Guo QQ; Yang J; Wolf P; Power NE; Durfee PN; MacMillan CD; Townson JL; Brinker JC; Fleshner NE; Izawa JI; Chambers AF; Chin JL; Leong HS
    Oncotarget; 2016 Feb; 7(8):8839-49. PubMed ID: 26814433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative urinary proteomics using stable isotope labelling by peptide dimethylation in patients with prostate cancer.
    Li C; Zang T; Wrobel K; Huang JT; Nabi G
    Anal Bioanal Chem; 2015 May; 407(12):3393-404. PubMed ID: 25724369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of potential RNA biomarkers for prostate cancer diagnosis and monitoring in plasma and urinary extracellular vesicles.
    Brokāne A; Bajo-Santos C; Zayakin P; Belovs A; Jansons J; Lietuvietis V; Martens-Uzunova ES; Jenster GW; Linē A
    Front Mol Biosci; 2023; 10():1279854. PubMed ID: 38099195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.